Welcome to Our stocktraders-icq.com© Website.
WARNING – After-hours investing involves unique risks. These risks may include greater price volatility, less liquidity, and wider bid/ask spreads than during regular market hours.
The Week Past
Well, we had the Dow down last week by finishing -2.6% for the week, the Nasdaq finished the week +2.4%, The S & P 500 was -1.1%, and the Russell 2000 was +0.6%. All traders should pay closer attention to their mental stops or plan on riding out some bumps along the way.
This last week was a medium downturn for the Dow and a medium upturn for the Nasdaq. We believe margin is fine to use if you DO NOT margin all your holdings. We feel it would be prudent to have 1/2 of an account on margin at this time.
We believe that a long-term or swing-trader should have 1/3 of their portfolio on margin at this time. A daytrader could have some margin of up to 1/2 of his holdings if you use tight stops. We want short-term traders to have their stops in a tighter range of –5% to -10% We suggest using -20% stops on your long-term positions at this time.
Well, the Dow was down small and the Nasdaq finished the week down large.
Last Weeks Economic News
The Economic reports coming this week are: on May 24th at 8:30 Am EST the Initial Claims on joblessness report will be released and at 10:00 Am EST the New Homes Sales report will be released and on May 25th at 8:30 AM EST the Durable Goods Orders report will be released, at 8:30 AM EST the Gross Domestic Product (GDP) report will be released, and at 10:00 AM EST the Existing Home Sales report will be released.
This Weeks Economic News
The reports are: on May 29th at 8:30 Am EST the Personal Income and Consumption reports will be released and at 10:00 Am EST the Conference Board Consumer Confidence report will be released; on May 31st at 8:30 AM EST the Initial Claims for joblessness report will be released and at 10:00 AM EST The Philadelphia Fed Index and Chicago PMI reports will be released; and on June 1st at 8:30 AM EST the Auto and Truck Sales reports will be released and at 8:30 AM EST The Employment Report will be released. These reports will rate a C- to A on a scale of A-F. Everyone should place close attention to pre-market trading and how the futures are acting each morning before the market opens for trading.
IPOs by M_A_Trader©:
Ipos are not coming out now as the market goes lower. There will not be many ipos coming to the market so check them out on at this web site. Click on Ipo Info is a great site to research ipos.WARNING: IF YOU BUY IPOs AFTER THE STOCK OPENS USE LIMIT ORDERS ONLY.
We have heard FRONTIER OIL CORPORATION (NYSE: FTO) may become a takeover candidate at $15-16. This stock would be a very speculative play in the energy sector. Buy under $9 with a mental stop at $6 ½. Well, FTO is at $12.45 on May 15th so we would recommend a trader sell ¼ of their holdings and take some profits off the table if they bought below $9. Hold the rest for our $16 target and move the stop up to $11.75. Only use money you can afford to lose all of it in this type of trade.
FTO hit our stop of $11.75 on May 23, 2001 so if you still hold some FTO you should have been stopped out at a nice gain.
The FED cut rates 50 basis points on May 15, 2001. The Fed will next meet on June 26-27, 2001.
”A” Portfolio Stock Report by M_A_Trader©
We added MDT at $41.25 and AAPL at $23.25 to the “A” Portfolio on May 23rd, 2001.
AAPL ($22.76) News for AAPL: “WWDC 2001, SAN JOSE, Calif., May 21 /PRNewswire/ -- Apple(R) (HYPERLINK "/cgi-bin/details?Symbol=AAPL"Nasdaq: AAPL) today announced that it will become the first in the industry to move to an all LCD flat panel display pro lineup. At the center of the new display line, Apple unveiled the new 17-inch Apple Studio Display(TM), a digital LCD display featuring 1280 by 1024 resolution at an aggressive price of 999 (US). The company also announced that it has lowered prices for the other two digital LCD displays in its line, with the award-winning 22-inch Apple Cinema Display now available for 2,499 (US) and the 15-inch Apple Studio Display now available for just 599 (US). "Apple is the first company to move to an all LCD flat panel display lineup -- the all-digital desktop has finally arrived," said Steve Jobs, Apple's CEO. "Apple's complete line of affordable digital LCD displays are far brighter and sharper than the CRTs of old." Apple's line of flat panel displays are digitally-driven from the computer to provide crisper images than prior-generation analog-driven flat panel displays. An all-digital interface produces sharp, flicker-free images that never need to be adjusted by user controls such as CRTs require. The displays' active matrix technology provides extraordinary brightness and contrast with no image degradation. Ideal for creative professionals looking for a superior-quality, space-saving alternative to a traditional CRT monitor, the new 17-inch Studio Display flat panel offers an incredible screen resolution of 1280 by 1024 pixels and a full 16.7 million colors. Its incredibly wide viewing angle of up to 160 degrees maintains color fidelity even when viewing off axis. The 17-inch Studio Display continues the award-winning industrial design of its 15- and 22-inch siblings that is both beautiful and functional. In addition to its slim desktop footprint and low power consumption, the 17-inch Studio Display also features the Apple Display Connector, an innovative single-connection quick-latch mechanism that combines USB, power and video in one cable, for easy hookup and reduced desktop clutter. For easy plug-and-play connections to peripherals, the 17-inch flat panel also offers a 2-port powered USB hub. Apple's complete line of flat panel displays provide the perfect companion to Apple's latest desktop computers. The award-winning Power Mac(TM) G4 professional desktop offers either 733 MHz, 533 MHz and 466 MHz single-processor configurations, or dual processor 533 MHz PowerPC G4 processors with Velocity Engine(TM). The Power Mac G4 comes with a choice of optical drives and easy-to-use applications for creating music CDs, interactive DVD videos and desktop movies. Pricing & Availability The 17-inch (diagonal) Apple Studio Display flat panel is expected to be available in early June from the online Apple Store(R)HYPERLINK "http://www.apple.com"(www.apple.com), at Apple's retail stores and through Apple Authorized Resellers for a suggested retail price of 999 (US) the 15-inch (diagonal) Apple Studio Display flat panel for a suggested retail price of 599 (US), and the 22-inch (diagonal) Apple Cinema Display for a suggested retail price of 2,499 (US).” AAPL
We added MDT at $43.86; ISIL at $29.75; RETK at $29.75; and CTLM at $30.75 to our “A” Portfolio.
Here is some information on the above four stocks.
MDT ($42.50): Medtronic, Inc. News for MDT: “MINNEAPOLIS--(BW HealthWire)--May 22, 2001-- New AF Device-Based Treatment Reduces Severe Symptoms, Enabling Better Patient Quality of Life Providing new hope for a select group of often-hospitalized patients, Medtronic, Inc. (HYPERLINK "/cgi-bin/details?Symbol=MDT"NYSE:MDT), today announced U.S. Food and Drug Administration approval of a revolutionary device-based therapy that improves quality of life and reduces the debilitating symptoms of atrial fibrillation. The treatment is delivered by a system that includes the Medtronic GEM(R) III AT implantable cardioverter defibrillator (ICD) and the InCheck(TM) AT Patient Assistant. The InCheck AT Patient Assistant is a small handheld device that tells patients when their heart is experiencing atrial fibrillation. Patient's can then use the device to initiate their own atrial therapy, outside of the physician's office or clinic. The GEM III AT ICD is Medtronic's exclusive second-generation implanted device to be FDA-approved for a new group of patients whose primary indication is symptomatic fast heart rates in the upper chambers of the heart (atrial fibrillation) and for whom antiarrhythmic drugs have been ineffective. When used with the InCheck AT Patient Assistant device, the system helps patients restore sinus rhythm at the touch of a button, allowing them to resume the activities of daily life. The GEM III AT ICD includes Medtronic's proprietary AT(TM) Trio, a suite of arrhythmia management tools that help physicians know the patient's condition, protect the patient from the effects of atrial arrhythmias, and deliver therapies to restore the patient's normal heart rhythm. Atrial fibrillation is the world's most common sustained heart rhythm problem. Medtronic officials estimate that up to 5 percent of the 3.3 million patients in the U.S. with atrial fibrillation could potentially benefit from this new therapy. These patients typically suffer from prolonged periods of atrial fibrillation (24 hours or longer) and frequently must be hospitalized for electrical or chemical cardioversion therapy when medications have been ineffective. Severe AF symptoms include fatigue, shortness of breath, chest pains, heart palpitations and difficulty breathing, which may prevent patients from participating in activities such as shopping, climbing stairs, lifting and cooking. "For certain AF patients, this is the right therapy," said Dr. Michael Gold, Chief of the Electrophysiology Laboratory at the University of Maryland. "There are a number of patients whose lives are severely affected by atrial arrhythmias who have not received adequate help from medications in reducing their symptoms. My patients who've needed external cardioversion therapy to end atrial arrhythmia episodes have found that this therapy results in fewer hospitalizations. They feel better after using the implanted therapy and appreciate the control the patient-activated device gives them in managing their heart rhythm.” MDT
CTLM: Centillium Communications. News for CTLM ($28.03): No new news for CTLM CTLM
ISIL ($36.00): ISIL News for ISIL: “IRVINE, Calif.--(BUSINESS WIRE)--May 24, 2001-- Endura Power Management Circuits Deliver Power to Over 50 Percent of Next-Generation Microprocessors Intersil Corporation (HYPERLINK "/cgi-bin/details?Symbol=ISIL"Nasdaq:ISIL), a leading provider of power management solutions for PCs, file servers and portable information appliances, today announced that Intersil's Endura(TM) current sharing technology will power over 50 percent of Intel(R) Pentium(R) 4 processors. Intersil provides the highest performance and the most cost effective multiphase DC/DC converter for Intel's Pentium 4 processor. Nine of the top ten domestic computer original equipment manufacturers (OEMs), as well as Taiwan's first- and second-tier customers, have selected Intersil's Endura HIP6300 and HIP6600A-series power management chipsets for next-generation Pentium 4 designs. "Intersil's Endura multiphase chipsets will continue to dominate the market by being designed into over 50 percent of the motherboard models featuring next-generation Pentium 4 processors," said Rick Furtney, vice president and general manager of Intersil's Power Management product-line. "The quality, performance, ease-of-use, and reliability of Endura multiphase devices enable computer OEMs, motherboard manufacturers, and voltage regulator module suppliers to transition from concept to production in record time. Our multiphase chipsets arm customers with the ability to develop an easily reproduced Pentium 4 CPU DC/DC converter, a key factor for volume shipments of next-generation motherboards.” Intersil's Endura multiphase devices feature a high level of integration and proprietary architecture offering several system-design advantages. Intersil's innovative rDS(ON) sensing topology, coupled with other architectural features, enhances the converter's efficiency, improves transient response, and reduces overall bill-of-materials cost by eliminating the need for an external current sense resistor. The industry's most precise channel-to-channel current balance further reduces cost by eliminating the need for the over-design of each converter channel. Sophisticated features, such as the controller's ability to automatically reconfigure clock frequency based on the number of populated phases sensed, offers designers the flexibility of designing for a three- or four-phase Pentium 4 DC/DC converter with the same power IC. Endura devices allow for easy duplication of designs and layouts from one Pentium 4 motherboard model to another, dramatically reducing time to market and helping establish the Pentium 4 as a high-volume, mainstream processor.” ISIL
RETK ($39.15): etek Inc. News for RETK: No new news for RETK. RETK
We have added AXP at $37.50; FRE at $60.50; and XLF at $25.50 to the “A” Portfolio the last few weeks . All three stocks are in the financial sector. Here is some information on all three companies.
AXP American Express ($43.33). News for AXP: No new news for AXP. AXP
FRE ($64.16) News for FRE: No new news for FRE. FRE
Financial Sel Sect Spdr Fd (AMEX: XLF $28684) is a sector spider traded on the AMEX.
The upper resistance levels for the Nasdaq is 2,350 and then 2,575. Support is at 2,200 and then 2,100. We would like to see the Nasdaq stay above 2,100. The Dow has support at 11,000 and then 10,900. Resistance is at 11,300.
The “A” Portfolio is going to a strict percentage gain or loss sell mode for now with the market fluctuating so much at this time. If a position moves up +20% one-quarter of the position will be sold, at +40% another one-quarter will be sold, and then at +75 to +100% another one-quarter of the position will be sold. That will leave one-quarter of the position to ride the stock higher. We still will use –30% to exit a stock position. Our targets for these stocks are on our Charts page.
We will talk about more of the stocks in the “A” Portfolio in the coming weeks.
All the past additions to the “A” Portfolio are on this page now.”A” Portfolio Additions
Please read our disclaimer about the “A” Portfolio here. ”A” Portfolio Disclaimer
Stock Charts for 2000 and 2001
The Charts page will be up and running by the end of May 2001.This page has links to all our stock charts and “A” Portfolio results for 2001.The Charts
After we turn from overall market downward momentum to upward momentum these two Canadian companies should rebound well.
Infowave Wireless (IW:TORONTO) Target US$30 Infowave is well positioned to take advantage of the coming boom in wireless email. Thomas Koll(a current VP at Microsoft) will be starting as the companies CEO on February 15. They have many impressive partners including Intel, Nokia and Compaq. Current market conditions have made this stock very oversold.
Rogers Communications (RCB.A:TORONTO) Target US$42 Rogers is Canada's largest cable television company they also have their hands into providing high speed internet as well as cellular and paging services. The long-term outlook for this company is stable and is likely to see steady growth in a booming industry.
LEAPS® information is now on this page. LEAPS®
Stocks We Like
Research in Motion closed the week at $37.05 we have lowered our 12 month target to $155 (RIM, TSE) (RIMM, NASDAQ). News for RIMM: We are letting RIMM run for our target of $155. Since we already have PALM a trader may want to add HAND and have all three in their portfolio.We added RIMM at $40 ¼ and today March 28th we added more RIMM at $20.You may have to hold RIMM for 12 – 18 months depending on how the market is doing. RIMM has found partners in AOL and Compaq. Amazon has Crackberry available for $499 with service available at $39.95 per month. News for RIMM: No new news on RIMM. RIMM
VIRS (5.15 ) is a very speculative buy at this time. VIRS is a strong buy if it sinks down to $5 1/2 – 6 1/2 Only buy it if you can afford to lose all you invest in it. The chart for VIRS is looking good so continue to hold this stock for our $25 target. News from VIRS: No new news for VIRS now.
Management and product development strategy is available on Triangle's website at: VIRS
We are adding another blown up stock as a speculative buy. We are adding ZOOX (3.60), as a very risky buy at $2 ½ or lower with a target of $29 in 24 months. ZOOX is currently having a slow down in sales year to year. Its new switch for SANS are not selling as well as management expected. New management has been installed but it may take two or more quarters to fix their inventory oversupply. Well, ZOOX has not been doing very good since we recommended it a few months ago. We would average into more of ZOOX and hold for the long-term. ZOOX may be dead money for the next two-three quarters. News for ZOOX this week: No new news for ZOOX. Only buy this stock if you can afford to lose your entire investment in ZOOX.ZOOX
We are looking at adding IOM Iomega Corp. ($2.91) to our “A” Portfolio under $3.00. It has come out with a new storage device for home computers that will hold 10-20 Gigs of data. IOM is another beaten up high tech stock so only invest money in it you can afford to lose all.
Iomega Corporation designs, manufactures and marketsinnovative storage solutions, based on removable-media technology for personal computer & electronics device users.For the 3 months ended 4/1/01, sales fell 19% to $278.2M. Net income fell 81% to $9.8M. Revenues reflect a reduction in Zip(R) and Jazz(R) drive and disk sales. Net income also suffered from lower Zip margins, increased R&D expenditures and a higher effective income tax rate. IOM
News for IOM: “ROY, Utah, May 24 /PRNewswire/ -- Iomega Corporation (NYSE: IOM), a global leader in data management solutions, today announced that its new Peerless(TM) 10GB and 20GB drive system is now shipping. The Peerless drive system, winner of two editor's choice awards upon its introduction in January 2001 at CES and Macworld, is shipping more than a month ahead of schedule and marks the arrival of a new generation of portable high-speed storage devices. Configured with a USB interface module, the first Peerless drive systems are going to customers who pre-ordered through IOM. Iomega will begin shipping the system with FireWire(R) interface modules within weeks, and the Peerless drive system is expected to be widely available by late June when PC Expo opens in New York City. "Many of today's digital applications demand a storage system that is truly portable, truly high capacity, and truly high performance," said Doug Collier, senior vice president, marketing and product management, Iomega Corporation. "With pocket-sized Peerless disks, users can back up an entire hard drive, migrate computer systems, and automatically protect all of their vital data with Iomega's easy-to-use QuikSync file backup software." The Peerless drive system incorporates world-class technology based on IBM's Travelstar(TM) 20GN 2.5" notebook hard disk drive in 10GB and 20GB capacities. As the highest shock-rated removable hard disk drive, Travelstar provides Iomega's Peerless drive system with a solid technology platform in a rugged and reliable sealed disk that is roughly the size of a PDA. The Peerless disk slips into a base station only slightly larger than the disk itself -- a slim, vertical enclosure that minimizes the footprint on the desktop. The Peerless drive system's unique design lets users save money as they add capacity. The system's hard drive electronics are located in the base station, rather than on the disk itself, so users only have to buy the drive's electronics once. This industry-first technology is a product of collaborations between Iomega and IBM and results in disk prices as low as one cent per megabyte. The fully sealed disk design also eliminates the risk of dust contamination and allows sustained transfer rates up to 15 MB/sec with a FireWire(R) interface module. For more information about the Iomega Peerless drive system, please visit Peerless. Price and availability The Iomega Peerless drive system can be ordered today by residents of the U.S. through Order Shipments to international regions are expected to begin at the end of May. The drive with interface module retails for 249.95 (U.S. suggested retail price). Individual Peerless disks can be ordered today for 159.95 (10GB) and 199.95 (20GB) (U.S. suggested retail prices). The base station bundled with an interface module and a 20GB disk retails for 399.95 (U.S. suggested retail price). The base station bundled with an interface module and a 10GB disk retails for 359.95. FireWire interface modules are expected to be available within weeks.”
Over the next few weeks we will talk about the stocks in our “A” Portfolio. We added more IMNX ($16.24) to our “A” Portfolio because they still will sell all the Enbrel they can produce and have a waiting list for Enbrel. IMNX News for IMNX this week: No new news for IMNX.
Corvis Corporation CORV ($6.90) News for CORV: No new news for CORV. CORV
Sycamore Networks (SCMR) ($11.01) News for SCMR: No new news on SCMR.
Ceragon Networks Ltd. (CRNT $3.40) News for CRNT: No new news for CRNT. CRNT
Capstone Turbine Corp. CPST ($35.79) News for CPST: No new news for CPST. CPST
CORR ($33.55) News from CORR: No new news for CORR. CORR
Three recent additions to the “A” Portfolio are being reported on.
EMBT ($31.25): News for EMBT: No new news for EMBT EMBT
PALM ($6.25) News for PALM: “STANFORD, Calif., May 23 /PRNewswire/ -- Palm, Inc., a pioneer in the field of mobile and wireless Internet solutions and a leading provider of handheld computers, and West Group, the foremost provider of e-information and solutions to the U.S. legal market, are working with Stanford University's Law School on a six-month wireless handheld technology initiative that is allowing busy law school students to communicate, research, prepare for exams and manage their studies remotely. The 50-person student and faculty program was conceived by Mitch Davis, chief information officer and associate dean for Information Systems at the Law School, and is part of the school's overall wireless initiative. West Group is providing wireless access to Westlaw(R), the legal industry's most powerful and comprehensive legal research service, and six eBook titles that will give students remote access to frequently used legal information. The company also is providing training and additional funding for the program. West Group and other software companies -- PDA Verticals, Ury Fischer Esq., NearSpace, Town Compass and Elite.com -- are providing legal, Stanford-specific and time-and-billing software. Students and faculty chosen to participate in the program paid 100 (for the cost of the keyboard) and received a Palm(TM) VIIx wireless handheld, a portable keyboard, downloadable software, and six months' worth of wireless access. The initiative incorporates a three-month training program and a number of focus groups. Law students, who secure summer jobs in law firms, for example, will discuss their use of the technology upon returning to school in the fall. Upon completion of the program, the participants will be allowed to keep the products, but will pay for ongoing wireless access. "The legal profession as a whole is embracing wireless technology because access to the latest legal information anytime is such an obvious advantage," said Davis. "This initiative is an excellent opportunity to help students become conversant with the technology, use it in school and carry it forward in their professional lives." "This program is part of our strategy to bring the power and convenience of handheld computing to colleges and universities -- especially those offering research-intensive programs such as law," said Mike Lorion, Palm's vice president of education markets. "We expect this initiative will serve as a model for universities that want to provide their students simple, quick, fun and smart ways to communicate and learn remotely.” PALM
CMRC ($8.25): News for CMRC: No new news for CMRC. CMRC
New stocks for this newsletter are: HAND, CHIR, and MLNM.
HAND ($10.21) Handspring, Inc. News for HAND: No new news for HAND. HAND
CHIR ($53.05) Chiron Corp. is a biotechnology company that is developing products for preventing and treating cancer, infectious diseases and cardiovascular disease. News for CHIR: No new news for CHIR. CHIR
MLNM ($41.54) News for MLNM: No new news for MLNM. MLNM
JDSU ($21.26) News for JDSU: No new news for JDSU. JDSU
MYGN ($67.20) News for MYGN: “SALT LAKE CITY, May 23 /PRNewswire/ -- Myriad Genetics, Inc. (HYPERLINK "/cgi-bin/details?Symbol=MYGN"Nasdaq: MYGN), provided an unrestricted educational grant to the American Medical Association that was used to prepare and distribute up to 75,000 physician education modules on hereditary colon cancer, entitled, "Identifying and Managing Risk for Hereditary Nonpolyposis Colorectal Cancer and Endometrial Cancer (HNPCC)," the Company announced today. The education modules provide physicians with up to three hours of AMA PRA Category 1 Continuing Medical Education (CME) credit upon completion. "Myriad funded a similar program with the AMA on hereditary breast and ovarian cancer that was very successful," said Gregory Critchfield, M.D., President of Myriad Genetic Laboratories, Inc., the Company's wholly owned predictive medicine subsidiary. "The AMA has now introduced educational modules on the hereditary aspects of four of the leading cancers among women, representing over 300,000 new cases annually of breast, ovarian, endometrial and colon cancer in the United States alone. Myriad's BRACAnalysis and COLARIS tests, covering these diseases, provide hope and empowerment to affected women and their families, helping them live longer, healthier lives." The AMA co-developed the CME monograph with the leading medical association dealing with the prevention of colon cancer, the American Gastroenterological Association, to create a thorough educational module explaining the basis of hereditary colon cancer. The module contains a review of the genetics of hereditary colon and endometrial (uterine) cancer and the risks associated with hereditary gene mutations, as well as discussion of the clinical and pathological features of the disease. A comprehensive treatment of genetic evaluation of patients with guidelines for appropriate patient selection and interpretation of results complements the information on implications for medical care of patients with a heightened risk of hereditary colon and endometrial cancer.” MYGN
PFE ($41.86) Pfizer Inc. News for PFE: “NEW YORK, May 24 /PRNewswire/ -- Pfizer Inc said today that it is pleased that an FDA advisory panel affirmed that its alpha-blocker Cardura (doxazosin mesylate) is safe and effective as currently labeled for its indications of high blood pressure and benign prostatic hyperplasia. Pfizer said it will continue to work closely with the U.S. Food and Drug Administration and other regulatory agencies around the world as additional data from the ALLHAT trial becomes available to determine whether label additions are warranted. The advisory panel was reviewing data from a clinical trial sponsored by the National Institute of Health. In that trial, known as ALLHAT, preliminary results showed a lower incidence of CHF in patients taking a diuretic, a commonly used treatment for CHF, for which Cardura is not indicated. In its presentation to the FDA panel, Pfizer said that a review of 316 Pfizer-sponsored clinical trials involving over 49,000 patients concluded that Cardura does not cause congestive heart failure (CHF). Further, neither Pfizer's own post-marketing database nor a review of 27 scientific articles that tracked nearly 6,000 patients showed evidence that Cardura is causally associated with CHF, heart attack or stroke. Cardura, which was approved in the United States in 1990, has accumulated over four billion patient days of experience.” PFE
With the Market being so volatile, a trader should have some close mental stops in the stocks they buy. We suggest a mental stop of 20% is used where appropriate.Income and Bonds
We recommend buying utilities based in Florida and not any utilities based in California. The reason is California based utilities do not produce enough of their own power and have to go onto the open market to buy power during peak usage. California utilities are having trouble and two of them Edison Intl. (EIX) and P G & E Corp. (PCG) are having problems so stay away from them for now. PCG has declared bankruptcy last week and Edison Intl. (EIX) has said they will not declare bankruptcy for now. We would stay away from any power generators that supply power to any California utilities at this time. For a person needing some income be sure to look into electric utilities for some bargain buying opportunities to take advantage of the high dividend paying utilities. We would buy 5-year and 10-year treasuries for income and some appreciation if interest rates were lowered more this year. We recommend 3-6 months Treasuries because they are currently yielding 4.0%. CEI yield has gone down to 9.8% but it is still a buy for its yield and our target is $35. We also like these two reits: CRE yielding 6.5% CarrAmerica Realty is a REIT that focuses primarily on the acquisition, development, ownership and operation of office properties in suburban growth markets in the U.S. Forthe FY ended 12/31/00, revenues rose 8% to $558M. Net income from continuing operation fell 3% to $147.2M. Revenues reflect the development of properties being placed in service and higher occupany rate for store properties. Earnings were offset by a lower gain on the sale of assets. CRE and SPG yielding 7.81% Simon Property Group, Inc. is a self-administered and self-managed REIT company, primarily engaged in the expansion & development of real estate properties, primarily malls and shopping centers. For the fiscal year ended 12/31/00, revenues rose 7% to $2.02B. Net income before extra item & acct. change, applic. to Common and limited partners rose 14% to $347.4M. Revenues reflect the CPI merger. Net income reflects gains vs. losses on RE sales. SPG
We have another energy stock we like that has some risk but not as much risk as some of the other energy stocks out in the market. The stock is Entergy (ETR). We added ETR ($43.30) to the “A” Portfolio at $38.50 on April 16th, 2001. News on ETR: No new news for ETR. ETR
Stocks for 2001
The new stocks we have added to our charts for 2001 are: INSP; IMNX; ICOS; TQNT; TGEN; SBUX; RSTA; CRXA; COST; WM; ISLD; MCOM; CHKP; EMLX; ITWO; MANU; JNPR; MUSE; VRTS; QLGC; VRTY; ACRT; AREM; CHCS; INRS; PWER; PDII; SNWL; CHEZ; KO; CORV; GPS; GSPN; MDT; MRCY; AMCC; VTSS; XLNX; BKE; MYGN; CHIR; APC; DVN; JNY; MCLD; NBR; PTEN; QQQ; and TXN. We dropped the following stocks: T; EWEB; ROWE; SGAI; PCOR; PCNTF; ICY; AND LU. You will notice there we be more sections in the charts section of the website. We still will have sections called 12 month, Like, and Tracking. With new sections for Beaten up stocks from 2000, an ADV section for stocks new to our Newsletter, and a section called Dogs of the Dow. Dogs of the Dow are five stocks chosen from the Dow Jones Average of 30 stocks that has shown to beat the market over the past few years.
Some the company’s reports written about Stocks 2001 in the newsletter are here Stock Picks 2001
With the Market being so volatile, a trader should have some close mental stops in the stocks they buy. We suggest a mental stop of 30% is used where appropriate.
Readers will notice all our stocks we follow are on a separate page and we will list prices to purchase stocks at and a target price that we feel the stocks have of reaching in 12 months.